Patient advocates hope Dr. Michelle Tarver will lead the agency to focus more on safety and less on rapid approvals. Regulation and Deregulation of Industry, Ethics and Official Misconduct, Appointments and Executive Changes, Medical Devices, Politics and Government, Food and Drug Administration, Shuren, Jeffrey E Patient advocates hope Dr. Michelle Tarver will lead the agency to focus more on safety and less on rapid approvals. NYT > Business
FDA Names a New Chief of Medical Devices
